Treatment and Outcomes of Primary Urethra Cancer

Tony Y. Eng, Tiffany W. Chen, Abhilasha J. Patel, Jill N. Vincent, Chul S. Ha
2018 American Journal of Clinical Oncology  
Urethral cancer is a rare malignancy, representing <1% of all malignancies. Optimal management, due to its rarity, presents as a treatment dilemma for physicians. There is a lack of consensus regarding treatment as large randomized trials cannot be performed; thus, optimal management decisions rely on study of retrospective cases. This is a review of our institutional experience with urethral cancer treated with various treatment modalities.
doi:10.1097/coc.0000000000000391 pmid:28537991 fatcat:j35l4s2mpvc6fj2o5pxqrahxku